CCR2 and neoplasm: CCL2/CCR2 recruits inflammatory monocytes that differentiate into tumor-associated macrophages (TAMs), often assuming immunosuppressive, pro-angiogenic phenotypes that blunt cytotoxic T-cell control [45,46].